The 5' end of this mRNA (1-1) carries a continuous coding sequence. The N-terminal 80 amino acids of the predicted product exhibit about 50% identity with segments in the ORF lb proteins of both EAV and LV. These segments are located 117 to 150 amino acids upstream of the C termini of the ORF lb proteins of these viruses. The 5' end cDNA clone contains part of a 5' leader associated with all seven subgenomic mRNAs and the 5' end of ORF la. The junctions between the 5' leader and the bodies of all seven subgenomic mRNAs have been determined. Only a single junction sequence was detected for each mRNA. Linkage occurs between a 5' UAUAACC 3' sequence at the 3' end of the leader and only partially identical segments specified downstream in the genome preceding ORFs 2 to 7. The generated junctions differ for different subgenomic mRNAs but possess the consensus sequence 5'
Introduction
Lactate dehydrogenase-elevating virus (LDV) is a mouse virus which invariably establishes a life-long, viraemic, but asymptomatic infection in mice regardless of their strain, age or sex or the route of inoculation (Plagemann & Moennig, 1992) . The persistent infection is maintained by cytocidal replication of LDV in a non-essential, renewable subpopulation of macrophages and escape
The nucleotide sequence data have been assigned GenBank accession numbers L06811 and L06812. from all host defence mechanisms. In addition, LDV infections can result in fatal poliomyelitis, but only in immunosuppressed mice of certain high leukaemic strains (e.g. C58 and AKR; Plagemann & Moennig, the Molecular Biology Information Resource (Lawrence et al., 1988 (Lawrence et al., 1989a (Lawrence et al., , 1988 (Lawrence et al., -1989b . More specifically, sequence similarities were assessed using Lawrence's implementation (Lawrence & Goldman, 1988 ) of Altschul's DD algorithm (Altschul & Erickson, 1986 ) with a minimum domain length of 15 and kmatch of one. Amino acid comparisons were performed with the same algorithm and parameters, but using the Dayhoff PAM 250 matrix as a basis. Fig. 5 and 6 are graphic representations of the textual output of these comparisons, with related regions labelled as percentage similarity.
SI nuclease protection experiments, pCR 1000 clones containing LDV inserts 323-3-4 and 323-5-6 (see Table 1 ) were digested with EcoRI (BRL) and HpaI or EcoRI and StuI (Boehringer Mannheim) restriction endonucleases, respectively. EcoRI cuts within the vector 22 or 26 nucleotides upstream of the LDV inserts and HpaI and StuI cut within the LDV sequences (see Fig. 11 ) releasing fragments of 185 or 181 and 85 or 81 nucleotides, respectively. The fragments were purified by gel electrophoresis and end-labelled with [7-32P]ATP using T4 polynucleotide kinase (Boehringer Mannheim) as recommended by the supplier. The probes were heat-denatured and, along with RNA from LDV-infected or uninfected macrophage cultures, precipitated with ethanol. The nucleic acids were hybridized in hybridization buffer containing 80% formamide, 2 M-NaC1, 0-2 M-PIPES pH 6.4 and 5 mM-EDTA at 45 °C overnight. The mixtures were then diluted 10-fold with S 1 buffer containing 1.35 units S1 nuclease/ml (Boehringer Mannheim). At various times of incubation at 45 °C, samples of the reaction mixtures were extracted with phenol-chloroform. The remaining nucleic acids were ethanol-precipitated, heat-denatured, and electrophoresed in denaturing sequencing gels together with a sequencing reaction of a clone of known sequence using a [c~-32p]ATP end-labelled primer which supplied appropriate size markers.
Results

Nucleotide sequence of 3.7 kb 3" end of LDV-P genome and potential functions of encoded proteins
We have previously reported the sequence of the 3'-terminal 1314 nucleotides of the LDV-P genome (Kuo et al., 1992) and have now extended the sequence to 3699 nucleotides ( Fig. 1) . This segment encompasses all seven ORFs expressed at the 5' ends of the subgenomic mRNAs of LDV ( Fig. 1 a and b) . The additional sequence has been deduced from the cDNA clones and cloned PCR products aligned in Fig. 1 (b) . The PCR products were generated by reverse transcription of total RNA, extracted from 6 to 7 h LDV-infected macrophage cultures, and genomic RNA using random hexanucleotide or 3' end-specific antisense oligonucleotides as primers and PCR amplification of the first-strand cDNAs, using these antisense oligonucleotides and in addition usually a 5' leader-specific sense oligonucleotide primer (Table 1) . These PCR products yielded information on the sequence of the LDV genome as well as on the sequences of the junctions between the 5' leader and bodies of the seven subgenomic LDV mRNAs (see later).
Only a total of 24 nucleotide ambiguities arose in the sequence derived from the cDNA clones shown in Fig.  1 (b) , including 12 between A and G and 8 between C and T. Twelve of these nucleotide ambiguities affected encoded amino acids (see Fig. 1 ). These nucleotide differences between different cDNA clones may be partly due to PCR errors since A + T ~ G + C transitions are not uncommon in PCR amplifications using Taq polymerase (Eckert & Kunkel, 1991) . They result from cytosine deamination at elevated temperatures and T + G mispairing. However, most of the nucleotide ambiguities probably reflect heterogeneity in LDV-P populations. The presence of LDV variants in the virion populations can be expected since, as a result of the high mutation rates of RNA viruses, even cloned populations of these viruses contain a large spectrum of mutants, a genomic distribution referred to as quasispecies (Steinhauer & Holland, 1987) . Furthermore, we have observed marked differences in the T-terminal 1181 nucleotides of the genomes of two LDV isolates, LDV-P and LDV-C (Kuo et al., 1992) . A to G and C to T differences also predominated, even though the genomic sequences were not derived from PCR products.
The sequence contains six major overlapping ORFs and one continuous coding sequence at the 5' end (Fig.  1 and Table 2) . A complication arose when numbering the mRNAs and ORFs. It has been the convention recommended for the nomenclature of coronaviruses (Cavanagh et al., 1990) and also used for toroviruses (Snijder et al., 1990) , EAV (den Boon et al., 1991) and LV (Meulenberg et al., 1992) to refer to the ORFs by the number of the mRNA from which the ORF is translated and to number the mRNAs in order of decreasing size. However, the 3'-coterminal nested set of LDV mRNAs contains one more member than those of EAV and LV, namely a larger approximately 4 kb subgenomic mRNA (Kuo et al., 1991 (Kuo et al., , 1992 and sequence analysis (Fig. 1 a) showed that this mRNA encodes the C-terminal 200 amino acids of ORF lb (see later). We have therefore designated this mRNA 1-1. The other mRNAs were then designated 2 to 7 as were their ORFs (Fig. 1, Table 2 ), thus correlating with those of EAV and LV: ORFs lb, 2, 5 and 7 are read in one frame, ORF 4 in another frame, and ORFs 3 and 6 in the third frame ( Fig. 1 a, Table 2 ). As reported previously (Kuo et al., 1992) , ORFs 5 and 6 and ORFs 6 and 7 overlap by 10 nucleotides. ORFs 2 and 3 and ORFs 3 and 4 overlap by 130 and 106 nucleotides, respectively, and the termination codon of ORF 4 overlaps with the initiation codon ofORF 5 (Fig.  1 a) . Such extensive overlapping of genes is unique for the LDV, EAV and LV group among animal RNA viruses. The especially extensive overlaps between ORFs 2 and 3 and ORFs 3 and 4 ( Fig. 1 b) are observed for all three viruses.
The ORF 7 product is VP1, the nucleocapsid protein (12.4K; Godeny et al., 1990 ) and the ORF 6 product is probably VP2 (18"8K), the non-glycosylated envelope protein (Kuo et al., 1992 
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. The products of ORFs 2 to 5 have not been identified. They all possess several potential N-glycosylation sites (Fig. 1 a, Table 2 ) and an N-terminal potential signal peptide sequence (Fig. 2a to d) , their predicted Mrs (Table 2) are very similar and about equivalent to that of the smallest form of VP3, the envelope glycoprotein, isolated from virions (Cafruny et al., 1986) , and hydrophobic moment analyses of the predicted proteins identify one to three potential membrane-spanning segments (Fig. 2a to d) been described previously (Kuo et al., 1992) . cDNAs L-192, L-194-1 and L-194-2 have been derived from a cDNA library; the remainder were generated by reverse transcription of RNA from LDV-infected macrophages or genomic RNA and PCR amplification of the transcripts as summarized in Table 1 . The arrows indicate the locations where the 5' leader is joined to the bodies of mRNAs 1-1 and 2 to 7. 427-2-3, -1-16 A1360 BI834/PI-2 ORF lb; J~ mRNA 1-1 423-3-1, -2 A1360 BI834/PI-2 ORF lb; J mRNA 1-1 423-4-1, -2, -4, -7, -10, -11 A1360 PI-I/A1360 ORF lb 403-5-6-1, -3, -12 CI001 BI834/AI360 J mRNA 2 381-3b-2, -3, -6 B1837 B1834/C1001 ORF 2; J mRNA 2 340s4-11 B1837 B1834/B1837 ORFs 2 and 3; J mRNA 3 323-4-2 B1151 B1834/B1837 ORFs 2 and 3; J mRNA 3 393-3, -5, -7, -9 CI00t BI834/C1001 J mRNA 3 340i5-0, -6, -8 B1837 B1834/BI837 ORFs 3 and 4; J mRNA 4 348-3, -10 B1151 B1838/BI836 ORFs 4 and 5; 381-8b-1, -2 Random B1834/BI836 ORFs 4 and 5; J mRNA 5 403-4-2, -9 Random Bl834/C1008 ORFs 4 and 5; J mRNA 5 340s8-2; 323-5-6 B1151 B1834/B1836 ORF 5; J mRNA 6 344i4-2-4 B1836 BI834/B1836 J mRNA 6 344sl-2 Random BI834/B1836 J mRNA 6 323-3-6; 6-3 Bl151 BI834/B1151 J mRNA 7 323-3-4 Bl151 BI834/B1835 J mRNA 7 * All clones were generated by reverse transcription of RNA extracted from 6 to 7 h LDVinfected macrophage cultures, except for those of the 423-4 series which were generated by reverse transcription of genomic RNA. For alignment of the clones, see Fig. l(b) . t Oligonucleotide B1834 is 5' leader-specific (see Fig. 7 ). All other oligonucleotides are derived from various sections of the 3' end encompassing ORFs 2 to 7 and the 3' end of ORF lb (for positions see Fig. la) .
J, Junction sequences between the 5' leader and the bodies of the mRNAs (see Fig. 10 ). (Fig. 2d) . However, such a structure would explain the apparent smoothness of the surface of LDV virions (Brinton-Darnell & Plagemann, 1975; Stueckemann et al., 1982) and perhaps the finding that antibodies neutralize LDV infectivity only very inefficiently . The EAV ORF 5 protein also possesses three similar potential membranespanning segments, but after cleavage of the signal peptide possesses an external N-terminal segment of about 75 amino acids with one carbohydrate side-chain (den Boon et al., 1991; de Vries et al., 1992) . The product encoded by LDV ORF 4 ( Fig. 2c ) possesses a C-terminal transmembrane segment (amino acids 155 to 175) which could anchor the protein in a membrane. The product of ORF 3 (Fig. 2b ) possesses one potential internal membrane-spanning segment (amino acids 94 to 114). Two of its potential Nglycosylation sites are located towards the N terminus (amino acids 23 and 49) and four in the carboxyl end (amino acids 119, 133, 142 and 174). It also possesses an unusually high number of cysteines (11 out of 191 amino acids), but this is not the case for the corresponding proteins of EAV and LV. The predicted product of ORF 2 (Fig. 2a) also possesses a potential C-terminal transmembrane segment (amino acids 189 to 209) and three potential N-glycosylation sites. The predicted proteins of ORFs 2 to 4 of EAV and LV generally possess structures comparable to those of the equivalent LDV proteins. However, the ORF 3 product of LV and the ORF 4 product of EAV seem to lack internal or Cterminal transmembrane segments and thus may be ruled out as membrane glycoproteins. The mRNA 2 contains another smaller ORF that starts just downstream of the ORF lb termination codon at nucleotide 601 (Fig. 1 a) and is read in a frame different from that for ORFs lb and 2. Its initiation codon is in a relatively favourable context for translation initiation (Kozak, 1989) with G, A and G in positions -3, -1 and +4, respectively, relative to the A(+ 1) of the AUG initiation codon (see Fig. 1 a) . Translation of mRNA 2 therefore could yield a second protein of 70 amino acids.
The results with the 4 kb subgenomic mRNA (1-1) of LDV were unexpected. It is a genuine subgenomic mRNA since the 5' UGUAACC 3' segment (nucleotides 1 to 7, Fig. 1 a) has been shown to serve as the link for joining of the 5' leader (see later) and this RNA is produced in macrophage cultures infected with three different isolates of LDV (Kuo et al., 1992; see later) . The mRNA carries a continuous coding sequence at the 5' end ( Fig. 1) and sequence comparisons showed that amino acids 1 to 79 of the predicted product are 57"0 % and 48.1% identical to those of segments in the Cterminal regions of the ORF lb proteins of LV and EAV, respectively, and that an additional 13% and 17%, respectively, represent conservative differences (Fig. 3) . This segment falls within a larger region (domain 4) which shows similarity to the ORF lb products of coronaviruses (den Boon et al., 1991) . Domain 4 is characteristic of all coronaviruses but has no identified function. The homologous segments of 79 amino acids of LDV, EAV and LV are located 120, 117 and 151 amino acids, respectively, upstream of the C termini of the ORF Amino acid number Fig. 2 . Hydrophobic moment analyses according to Eisenberg et al. (1984) of the proteins predicted by LDV ORFs 2 to 6 (a to e, respectively). Potential transmembrane segments were identified on the basis of mean hydrophobicities (H) as follows: ORF 2 protein amino acids 3 to 23, H = 69.3% and amino acids 189 to 209, H = 57% ; ORF 3 protein amino acids 1 to 21, H = 62.4% and amino acids 94 to 114, H = 60.0 % ; ORF 4 protein amino acids 155 to 175, H = 67.6 %; ORF 5 protein amino acids 61 to gl, H = 54.1% or amino acids 83 to 103, H = 53-6% and amino acids 105 to 125, H = 53.0%; ORF 6 protein amino acids 12 to 32, H = 49.2%, amino acids 38 to 58, H = 65.0% and amino acids 68 to 88, H = 66.7 %. The diagrams in frames (d) and (e) indicate the potential organizations of the ORF 5 protein and VP2 in the LDV envelope, respectively. lb proteins. No significant identities have been detected between these C-terminal segments of the three viruses (e.g. see Fig. 5 and 6 ), whereas the identity extends toward the N terminus of the O R F lb protein (Kuo et al., 1992) .
We have no evidence at present that the 3' end of LDV O R F lb carried by subgenomic m R N A 1-1 is expressed. However, we see no reason why this should not be the case. The most likely initiation codon for translation is located 147 nucleotides downstream of the 5' leader junction sequence (see Fig. 1 a) . It is in a favourable context for initiation of translation (Kozak, 1989) with A, C and G in positions -3 , -1 and + 4, respectively (see Fig. 1 a) . The initiation codon is not present in the ORFs lb of EAV or LV. Initiation at this site would yield a non-glycosylated protein of 148 amino acids (16"6K; Table 2 ) without potential transmembrane segments (data not shown). The m R N A 1-1 encodes an additional O R F (nucleotides 106 to 266; Fig. 1 a) read in a different frame. Its potential product is a 54 amino acid protein without N-glycosylation sites and membranespanning segments. Its initiation codon precedes that for the potential O R F lb product but it is in an unfavourable context for translation initiation (Kozak, 1989) with C, G and U at positions -3 , -1 and + 4 and thus is probably not translated.
Correlation between organization of the ORFs and the subgenomic mRNAs
We have used antisense oligonucleotides to various segments of the 3'7 kb 3' terminus of the LDV genome (for location see Fig. 1 a) as probes in Northern blot hybridization analyses of R N A from infected macrophages to assess the relationship between individual ORFs and the subgenomic mRNAs. Oligonucleotide Bl151 complementary to the non-coding 3' end of the genome hybridized to all eight LDV RNAs ( Fig. 4a and  b) and so did the O R F 7-specific oligonucleotide B1835 (data not shown). As expected from its genomic location, oligonucleotide B1836 hybridized only to LDV RNAs 1 to 6 (Fig. 4a) , the O R F 5-specific oligonucleotide C1008 only to RNAs 1, 1-1 to 5, the O R F 4-specific oligonucleotide B1837 only to RNAs 1 to 4, oligonucleotide C1001 only to RNAs 1 to 3, the O R F 2-specific oligonucleotide A1388 only to RNAs 1 and 2 and the O R F 1b-specific oligonucleotide PI-2 only to RNAs 1 and 1-1 (Fig. 4b) . The results indicate that ORFs 2 to 7 are encoded at the 5' ends of LDV m R N A s 2 to 7, respectively, and that m R N A 1-1 clearly encodes the 3' end of O R F lb. These conclusions are further supported by a correlation between the observed sizes of the subgenomic m R N A s and those estimated from the lengths of the genome segments from the junctions of the 5' leader to the 3' end of the genome and assuming lengths of the 5" leader and the 3' poly(A) tail of 200 and 100 nucteotides, respectively ( Table 2 ). The results also explain the presence of a noncoding intergenic segment between the ORF encoded by the 4 kb m R N A of LDV (1-1) and ORF 2, which is also present between ORFs lb and 2 of EAV and LV, whereas all other downstream ORFs of all three viruses overlap ( Fig. 1 b) . All these mRNAs, except m R N A 7, are structurally polycistronic, but are thought to function as monocistronic mRNAs, only the 5'-terminal O R F being translated. However, this conclusion has not been proved and for overlapping ORFs read in different frames readthrough is possible via frameshift mechanisms (Hatfield et al., 1992) . Indeed, the ORFs lb of coronaviruses (Spaan et al., 1988 ; Lai, 1990) and EAV (den Boon et al., 1991) seem to be expressed via frameshift processes. In the case of ORFs 2 to 7 of LDV, EAV and LV, however, no established heptanucleotide frameshift signals (slippery sequences) are observed in the overlapping ORF segments and there are no typical downstream stemloop structures, both of which seem to be crucial for frameshifting (Hatfield et al., 1992) . Thus it seems unlikely that the downstream ORFs of the larger subgenomic mRNAs are expressed.
General sequence comparison of the 3" end of the LD V genome with those of EA V and L V and of the encoded O RFs
As documented already, a segment of the C terminus of the ORF lb protein exhibits considerable similarity between LDV, EAV and LV (Fig. 3) . This sequence homology extends to other regions of ORFs la and lb Amino acid number Fig. 6 . Amino acid sequence comparisons of the proteins specified by ORFs 2 to 7 of LDV and LV (b to g) and of peptide encoded by the 5' end of the LDV genomic sequence shown in Fig. l(a) with the C-terminal region of the ORF lb protein of LV (a). (Kuo et al., 1992; Meulenberg et al., 1993; see later) . On the other hand, the sequence identities in the genomic segments encoding ORFs 2 to 7 differ greatly for the three viruses. In comparing the LDV and EAV genomes, only a single 60-nucleotide long segment in ORF 5 with 60 % identity was detected under the standard conditions of our sequence comparisons. Additional nucleotide similarities were observed in discontinuous segments of ORFs 2, 5, 6 and 7 of 21, 31, 155 and 661 nucleotides, respectively, when the threshold S.D. score for detecting identical domains was lowered to 2. However, no significant amino acid identities were detected in the proteins predicted by ORFs 2 to 7, except for a 68 amino acid long segment in the C-terminal region of the ORF 6 product with 19.1% amino acid identity and two very short segments in the ORF 2 and 3 products (data not shown).
In contrast, extensive sequence relationships exist between the LDV and LV genomes in the 3' end segment (Fig. 5) . In fact, the two genomes are practically collinear and nucleotide identity of about 50% and higher is apparent over 72 % of the LDV sequence of about 3000 nucleotides encoding ORFs 2 to 7. Furthermore, ORFs 2 to 7 of LV overlap in a similar fashion and are read in frames corresponding to those of ORFs 2 to 7 of LDV: ORFs 2, 5 and 7 are read in the same frame, ORFs 3 and 6 in another frame and ORF 4 in the third frame (for corresponding ORFs of LDV see Table 2 ), even though the segment encoding ORFs 2 to 7 of LV is 109 nucleotides longer than that of LDV. The presence of these additional nucleotides is reflected by the small steps in the homology domain dot plot of the two genomes ( Fig. 5) and associated with the predicted LV proteins being slightly larger than the LDV proteins (Fig. 6) . As anticipated by the nucleotide homologies of the 3' ends of the LDV and LV genomes, extensive amino acid identities exist between the predicted ORF 2 to 7 proteins of LDV and LV (Fig. 6 ). Additional segments with 40 to 50% amino acid identity are apparent when the threshold S.D. score for detecting homology domains is lowered to 2 (data not shown). In addition, a considerable proportion of amino acid differences between the predicted LDV and LV proteins reflect conservative changes (data not shown). In contrast to the extensive similarities between ORFs 2 to 7 of LDV and LV, no significant nucleotide homology was observed between the Y-terminal 80 nucleotide long non-coding segment of the LDV genome and the corresponding 115 nucleotide long 3' terminus of the LV genome.
5' Leader of subgenomic mRNAs
LDV cDNA 4-37 (1731 nucleotides) has been tentatively identified as encoding the sequence of a 5' leader, or part of it, that becomes attached to all subgenomic mRNAs (Kuo et al., 1992). This conclusion has now been substantiated and the sequence of cDNA 4-37 determined (Fig. 7) . It was found that cDNA 4-37 hybridized to genomic RNA as well as to all subgenomic RNAs (Fig. 8 a) . An oligonucleotide complementary to the 5' end of cDNA 4-37 (A1260; see Fig. 7 ) also hybridized to all RNAs isolated from macrophage cultures infected with two different isolates of LDV (Fig.  8c) . The hybridization profiles matched that for oligonucleotide Bl151 representing the non-coding 3' end of the genome (Fig. 8 d) . In contrast, cDNA 4-18 (812 nucleotides), representing the 3' end of cDNA 4-37, only hybridized to genomic LDV RNA (Fig. 8b) . Thus oligonucleotide A1260 recognizes a segment that is part of the leader sequence present on all the mRNAs. The experiments described below indicate that the 5' UAUAACC 3' sequence just downstream of A 1260 (Fig,  7) represents a sequence involved in the formation of the junctions between the 5' leader and the bodies of the mRNAs.
5" End of ORF la
The putative ORF la initiation codons in the genomes of LDV (Fig. 7) Gorbalenya et al., 1991) contain papain-like cysteine protease (PCP) motifs which seem to function in the generation of 28K to 30K N-terminal la cleavage products. Sequence comparisons suggest that the putative L D ¥ ORF la protein encoded by cDNA 4-37 contains two such PCP motifs (Fig. 7) . The potential PCP active sites are C 76 and H 147, H 158 or H 231 and C 269/H 340 (see Fig. 7 ). Similar PCPs are encoded by other positive-strand RNA viruses (Gorbalenya et al., 1991) . Recent in vitro translation and mutagenesis studies have identified C 164/H 230 of the ORF la product of EAV as the candidate catalytic residues of a PCP of this virus (Snijder et al., 1992) . The PCP was found to direct an autoproteolytic cleavage between two downstream glycines (G 260-G 261) yielding a 29K N-terminal product (nspl) (Snijder et al., 1992 ). An equivalent cleavage site of the LDV ORF la product might be located in the sequence Y 380 YGY which would yield a cleavage product of about 43K (Fig. 7) . LV ORF la contains a YGYY sequence at a position similar to that of LDV ORF l a. In vitro translation of a transcript of cDNA 4-37 has yielded a product of the predicted size (K. S. Faaberg & P . G . W . Plagemann, unpublished results). Little similarity has been detected between the N terminus of the LDV ORF la protein predicted by the sequence of cDNA 4-37 and the corresponding segment of the EAV ORF la protein. This is limited to a stretch of about 100 amino acids beginning with the putative Y Y G Y cleavage site with about 38% amino acid identity. Much more extensive amino acid identity ( > 50%) exists between the N termini of the ORF la proteins of LDV and LV (data not shown), just as is observed for the predicted ORF 2 to 7 products. Fig. 9 . Nucleotide sequence of clone 323-3-4 and alignment with 5' leader sequence and genomic sequence from 3' end ofgenome. Clone 323-3-4 was generated by reverse transcription of total RNA from 6 h LDV-infected macrophages using the ORF 7-specific oligouucleotide B1835 as primer and amplification of the transcript by PCR using the 5' leader-specific oligonucleotide B1834 as alternate primer. 
Identification of the junctions between 5" leader and bodies of subgenomic mRNAs
The junctions have been identified as follows. Total RNA extracted from 6 to 7 h infected mouse macrophage cultures was reverse-transcribed in the presence of one or another of the oligonucleotides complementary to various segments of the 3" end of the genome covering the ORFs contained in mRNAs 1-1 and 2 to 7 (see Fig. 1 ). The products were amplified by PCR using the leaderspecific sense oligonucleotide B1834 (see Fig. 7 ) as alternative primer. The amplified products were cloned and sequenced. Only a single leader-body junction segment was identified for each mRNA (see Fig. 1 b) and the same junction was found in at least three independent clones. The following results exemplify the general approach. Pairing of the antisense ORF 7-specific oligonucleotide B1835 (see Fig. l a) with the sense, leader-specific oligonucleotide B1834 generated a 259 Fig. 11 . Sequences of 323-3-4 (a, with junction to mRNA 7) and 323-5-6 (b, with junction to mRNA 6) cloned in plasmid pCRI000 and summary of the products released from these plasmids by restriction with EcoRI and HpaI or EcoRI and StuI, respectively, and of nucleotide sequences expected to be protected in genomic and subgenomic mRNAs in S1 nuclease protection experiments. Vector and leader sequences are represented by letters in italics and boldface, respectively. The TT residues at the junction between them are identical in both. The third T in (b) was generated by TA cloning. The sequences represented by oligonucleotides B1834, B1835 and B1836 are underlined.
nucleotide long product (323-3-4). The sequence of clone 323-3-4 contained, 5' to 3' (Fig. 9) , 31 nucleotides from the 5' end of cDNA 4-37, a 5' TAACCA 3' hexanucleotide found at the 5' end of the genome (i.e. cDNA 4-37; see Fig. 7 ) as well as downstream in the genome, 135 nucleotides preceding the AUG initiation codon for ORF 7, and the 5' end of the ORF 7 up to the segment represented by oligonucleotide B1835. Two similar but larger clones (362 nucleotides long) were generated with oligonucleotide B 1151 complementary to the non-coding 3' end of the genome (see Fig. 1 ). We conclude that 5' UAACCA 3' represents the junction between the leader and the body of mRNA 7. The pertinent sequences of the 5' leader, the amplified mRNA sequence and the corresponding genome segment are presented in Fig. 10 (last set of three lines; the nucleotides are arbitrarily numbered 1 to 22 beginning from the 3' end of oligonucleotide B1834, see Fig. 7 ). Since the junction hexanucleotide (underlined, nucleotides 9 to 14) is the same in the 5' leader and downstream in the genome, no conclusions are possible as to where the leader becomes joined to the body of mRNA 7. It is clear, however, that the nucleotides preceding this common sequence were identical to those in the 5' leader and diverged from those in the genomic sequence preceding ORF 7 and thus seemed to be derived from the leader, whereas the nucleotides downstream of the junction (nucleotides 15 to 22) were derived from sequences preceding ORF 7.
Different junction sequences were identified in other mRNAs, but in each mRNA the junction was identical to the genomic sequence preceding its ORF rather than to the 5' leader segment (Fig. 10) . In mRNAs 1-1, 3 and 4 a G (nucleotide 8) preceded a common 5' UAACC 3' sequence and thus seems 3' end genome-rather than 5' leader-derived. The same mRNA 3 junction sequence was obtained in six independent PCR clones. However, an ambiguity arose in the junctions of both mRNAs 1-1 and 4 in that nucleotide 8 was an A rather than a G in one of four PCR clones. In contrast, the junction of mRNA 2 derived from six independent clones was lacking nucleotide 11 (A) present in the leader sequence and in the junction of mRNA 6 nucleotide 9 was an A in three independent clones rather than the U found in the leader.
In summary, the junction sequences between the 5' leader and the bodies of the subgenomic mRNAs differed considerably for different mRNAs and diverged from that of the 5' leader. The junction consensus sequence is 5' Av A 3' UaAA CC (nucleotides 7 to 13 in Fig. 10 ). In mRNA 7, the U and A in positions 1 and 2 are clearly derived from the 5' leader, but in mRNAs 1-1, 3 and 4 the G in position 2 seems to be derived from the 3' end genomic sequence. The same is true for the A in position 3 in mRNA 6 and the A of the 5' leader is missing in the mRNA 2 junction. However, regardless of these junction differences between the seven subgenomic mRNAs, only a single leader junction was detected for each (see Fig.  lb) .
It is also of interest that a short stretch of 10 nucleotides in the LDV genome just upstream of the junction segment preceding ORF 2 is identical to the 3' end of the 5' leader (see Fig. 10 , second set of three lines). Since the repeat sequence is located within ORF lb, it codes for amino acids (see Fig. 1 b) The length of the untranslated segment between the 5' leader junction consensus sequence and the translation initiation codon differs greatly for each subgenomic LDV mRNA. It is 147, 120, 74, 35, 26, 14 and 135 nucleotides for mRNAs 1-1, 2, 3, 4, 5, 6 and 7, respectively (see Fig. 1 
S1 nuclease protection experiments
The linkages of the 5' leader to the bodies of mRNAs 6 and 7 have been confirmed by S1 nuclease protection experiments. Plasmid pCR1000 containing the mRNA 7-specific 323-3-4 insert (Fig. 11 a) was digested with EcoRI and HpaI which yielded a DNA fragment in which one strand was 181 and the other strand 185 nucleotides long (due to the staggered cut by EcoRI). The DNA fragment consisted of 22 or 26 vector nucleotides plus sequences representing parts of the leader and of the body of mRNA 7 (see Fig. 11 a) . The probe was purified, 5' endlabelled and hybridized to total RNA extracted from 6 h LDV-infected macrophage cultures. The mixture was then incubated for various lengths of time with S1 nuclease and the products were denatured and separated by gel electrophoresis (Fig. 12a) . Two fragments were generated, one of about 128 nucleotides which corresponds in length to the 3' end genomic sequence of mRNA 7 to the 5' UAACCA 3' junction and one of about 161 nucleotides. The latter corresponds in length to the previously mentioned 3' end genomic sequence plus the leader sequence carried by clone 323-3-4 and thus must have resulted from the hybridization of the probe to mRNA 7 rather than genomic RNA or the larger subgenomic mRNAs. Two comparable fragments of S1 nuclease-resistant fragments were generated from a probe obtained by EcoRI and StuI digestion of pCR1000 with the 323-5-6 insert (generated with oligonucleotides B1836 and B1834; Fig. lib) . The probe was about 83 nucleotides long. After hybridization to RNA from LDV-infected macrophages and S 1 nuclease digestion, fragments of 26 to 30 nucleotides were obtained which correspond approximately in length to the 3' end genomic sequence of mRNA 6. A second more prominent fragment of about 61 nucleotides corresponded in length to the latter plus the leader segment carried by clone 323-5-6. These results further support the conclusion that the 5' UAAAACC 3' and 5' UAACCA 3' sequences represent the junctions between the 5' leader and the bodies of mRNAs 6 and 7, respectively (Fig. 10) . . S1 nuclease protection of junction segments of mRNAs 7 (a) and 6 (b). End-labelled DNAs composed of a vector sequence and segments representing part of the 5' leader, the junction sequence, and part of mRNAs 7 (clone 323-3-4) or 6 (clone 323-5-6) were hybridized to RNA from 6 h LDV-infected and uninfected macrophage cultures. The mixtures were then incubated with S1 nuclease for the indicated periods of time, and analysed by gel electrophoresis. In (a) the profile of the untreated labelled probe is also shown.
Discussion
The most striking difference between the expression of the LDV genomes and those of EAV and LV is that the 3'-coterminal nested set of subgenomic mRNAs of LDV consists of seven (Kuo et al., 1991 (Kuo et al., , 1992 rather than six mRNAs reported for the latter two viruses (de Vries et al., 1990; Meulenberg et al., 1993) . This difference has now been explained. Our data show that the additional LDV mRNA encodes the C-terminal 200 amino acids of ORF lb. It has therefore been designated mRNA 1-1. It is a genuine mRNA since it possesses the 5' leader which is linked to the body of the mRNA via a common junction segment. It is produced in cultured macrophages infected with three different LDV strains and in spleens of LDV-infected mice (Kuo et al., 1992) . Further work is required to determine whether this mRNA is translated. It could yield a 16"6K protein representing the C terminus of the ORF lb product. In vitro translation experiments have shown that during processing of the ORF lb protein of mouse hepatitis virus (MHV) the Cterminal region containing most of domain 4 is cleaved off as a 32K protein (Denison et al., 1991) . The function of this protein has not been identified. The 16.6K LDV protein might represent an equivalent product which becomes amplified via formation of a separate subgenomic mRNA. The mRNA 1-1 encodes another ORF read in a different frame, but its initiation codon is in an unfavourable context for translation initiation and its potential product of 54 amino acids is therefore unlikely to be produced. On the other hand, the initiation codon of the alternative ORF contained in mRNA 2 is in a relatively favourable context for translation initiation and this mRNA therefore could yield two different proteins of 26K and 9K. Elucidation of the origin of the additional unique LDV mRNA made it apparent that overall the genomes of LDV, EAV and LV are organized in the same manner. Furthermore, the potential products of ORFs 2 to 7 of the three viruses are very similar in size and structure. LDV and LV are very closely related, whereas EAV is more remotely related.
The mode of synthesis of the subgenomic mRNAs of these three viruses and of the joining of the 5' leader to the bodies of the subgenomic mRNAs remain to be elucidated. Our data indicate that the formation of the junctions between the 5' leader of LDV and the bodies of its subgenomic mRNAs 1°1 and 2 to 7 is difficult to explain on the basis of the leader-primed transcription mechanism proposed for the synthesis of the subgenomic mRNAs of coronaviruses (Baric et al., 1983; Spaan et al., 1988; Lai, 1990; Yokomori et al., 1992) . This model postulates that the plus-strand leader is transcribed by the replicase from a full-length minus-strand antigenome and that the leader then 'falls off' the template and reassociates at complementary sites in intergenic regions downstream in the minus-strand template acting as primer for continued transcription. The 3' end of the leader sequence in genomic MHV RNA is composed of two or three repeated 5' UCUAA 3' heptanucleotides followed by a consensus 5' UCUAAAC 3' sequence and two or three repeats of the same or closely related segments are found upstream of the initiation codon of every ORF (Baric et al., 1983; Makino et al., 1986 Makino et al., , 1988 Makino et al., , 1991 Shieh et al., 1987; Spaan et al., 1988; Lai, 1990) . For example, the intergenic segment preceding ORF 7 of MHV A59 contains an 18 nucleotide long segment that is identical to the 5' leader sequence. However, the rules that determine the joining of the 5' leader to the bodies of the subgenomic mRNAs are not fully understood (Lai, 1990; Makino et al., 1991 ; Jeong & Makino, 1992; La Monica et al., 1992) . Furthermore, the discoveries of subgenomic negative strands in coronavirus-infected cells (Hoffmann et al., 1990; Sawicki & Sawicki, 1990; Sethna et al., 1989) and of subgenomic mRNAs in purified virions (Sethna et al., 1989) suggest that the formation of the subgenomic mRNAs may be more complex than initially postulated and may involve the independent replication of the subgenomic mRNAs .
The 3' ends of the genomes of LDV, EAV and LV differ in a fundamental way from those of the coronaviruses. The coronavirus ORFs that are expressed via subgenomic mRNAs are separated by intergenic untranslated segments which contain the sequence repeats which function in 5' leader joining. In contrast, all corresponding adjacent ORFs of LDV, EAV and LV overlap with each other. For each subgenomic mRNA, the segment in the genome where the 5' leader becomes joined to the body of the mRNA during its synthesis is therefore located in the next ORF upstream (Fig. 1 a and  b) . These junction sequences preceding each ORF in the genome are much shorter than those in the coronavirus genomes. Furthermore, these genomic segments are identical to the junction segments of the corresponding subgenomic mRNAs and generally different from the junction segment of the 5' leader (see Fig. 10 ). The 5' leader junctions of the seven mRNAs are very similar but differ from each other by one or more nucleotides for most mRNAs (Fig. 10) . Only the junctions for mRNAs l-l, 3 and 4 are identical. In addition to sequence differences in the junction segments the lengths of the homologous segments between leader, mRNA and the 3' end genomic sequence differ considerably for the seven subgenomic mRNAs (Fig. 10) . Thus only a heptanucleotide consensus sequence, 5' UGAA_CCA~J A ~ 3,' could be identified of which only the 5' U is consistently present in the leader. In mRNAs 1-1, 3 and 4, only this one U and in mRNA 6 only two nucleotides of the junction seem to be derived from the 5' leader (Fig. 10) . This seems to leave insufficient complementarity between the 5' leader and the downstream sequences to allow for leader-primed synthesis. It has been suggested that observed mismatches between the leader segment and the junction segments in the subgenomic mRNAs of MHV could result from trimming back of the 5' leader once it has bound to the minus strand template (Shieh et al., 1987; Lai, 1990) . It seems doubtful that such a process can explain the formation of the mRNA junctions of LDV. Firstly, such processing would require that the leader is held onto the minus strand template during trimming-back by factors other than hybridization between complementary nucleotides since the one or two nucleotides derived from the leader would be insufficient to accomplish this association. Secondly, the homologous segment at the 3' end of the 5' leader and those preceding each ORF are rather short, diverge considerably (Fig. 10) and sequence-related segments are found throughout the LDV genome but are excluded from functioning in 5' leader joining. It is clear that the 5' leader joining sites are highly specific since only a single leader junction has been detected for each subgenomic mRNA (Fig. 1) . However, what properties identify these diverse sites for joining of the leader is unclear. Perhaps factors other than sequence identity, such as secondary structure or participation of viral proteins, play a role. On the other hand, the heptanucleotide 5' UAUAACC 3' present at the 3' end of the 5' leader seems unique; it is not found anywhere else in the 11 kb of the LDV genome sequenced at present. The EAV leader junctions, which have been identified only for the two smallest subgenomic mRNAs (6 and 7), 5' UCAAC 3' (den Boon et al., 1991 ; de Vries et al., 1990) , resemble those of LDV.
An alternative mechanism to leader-primed synthesis for generating subgenomic mRNAs is splicing. Splicing has been proposed as a potential mechanism for the synthesis of the EAV subgenomic mRNAs because u.v. inactivation studies have shown that the synthesis of all EAV RNA species was about equally affected by u.v. irradiation (van Berlo et al., 1982; de Vries et al., 1990) . The results differed from those obtained with MHV (Spaan et al., 1988; Yokomori et al., 1992) and suggested that the subgenomic EAV mRNAs are derived from a common genome-length precursor, that is a full-length plus strand (de Vries et al., 1990) . Furthermore, it was observed (de Vries et al., 1990 ) that the segment directly upstream of the proposed junction sequence in the EAV leader (5' UCUCUA 3") is identical to the 5' splice site of the self-splicing pre-rRNA of Tetrahymena and that this segment is followed downstream by an inverted partial complementary sequence (part of ORF la) comparable to the internal guidance sequences of group I introns (Cech, 1990) . The comparable sequences at the 5' leader junction segments of LDV and LV, 5' CACCUA 3' (see Fig. 7 ) and 5' ACCCUU Y, respectively, differ from that of the EAV segment but can also be arranged in a Pl-like stem-loop structure characteristic for the self-splicing group I introns. However, many aspects of the formation of the viral subgenomic mRNAs differ greatly from group I intron splicing, namely the use of multiple different Y junction sites, the large distance between the 5' and 3' junction sites (at least 9 kb) and the fact that junction formation involves two identical or close to identical 3' and 5' junction sites. Eukaryotic mRNA splicing is also quite distinct from what we know about the formation of the EAV and LDV mRNAs and is restricted to the nucleus (Maniatis & Reed, 1987) . Thus if splicing is responsible for the generation of the LDV, EAV and LV mRNAs, a novel mechanism distinct from group I intron and nuclear mRNA splicing must be involved.
